FOLH1 and neoplasm: (19) estimated microscopic tumor-absorbed doses to be higher than those of 111In (discussed above), and the second is that other PSMA-targeted Auger agents, such as [125I]I-DCIBzL and [58mCo]Co-PSMA-617, demonstrated minimal toxicity and extended antitumor efficacy in tumors at a similar level.